Bajou K - Search Results

1

Endothelial cell intracellular Ca2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration.

Lewalle JM, Cataldo D, Bajou K, Lambert CA, Foidart JM. Lewalle JM, et al. Among authors: bajou k. Clin Exp Metastasis. 1998 Jan;16(1):21-9. doi: 10.1023/a:1006555800862. Clin Exp Metastasis. 1998. PMID: 9502074

2

Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation.

Baramova EN, Bajou K, Remacle A, L'Hoir C, Krell HW, Weidle UH, Noel A, Foidart JM. Baramova EN, et al. Among authors: bajou k. FEBS Lett. 1997 Mar 24;405(2):157-62. doi: 10.1016/s0014-5793(97)00175-0. FEBS Lett. 1997. PMID: 9089282 Free article.

3

Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.

Devy L, Noël A, Baramova E, Bajou K, Trentesaux C, Jardillier JC, Foidart JM, Jeannesson P. Devy L, et al. Among authors: bajou k. Biochem Biophys Res Commun. 1997 Sep 29;238(3):842-6. doi: 10.1006/bbrc.1997.7398. Biochem Biophys Res Commun. 1997. PMID: 9325178

4

Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro.

Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noël A, Foidart JM. Lewalle JM, et al. Among authors: bajou k. Exp Cell Res. 1997 Dec 15;237(2):347-56. doi: 10.1006/excr.1997.3799. Exp Cell Res. 1997. PMID: 9434630 Free article.

5

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

Bajou K, Noël A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM. Bajou K, et al. Nat Med. 1998 Aug;4(8):923-8. doi: 10.1038/nm0898-923. Nat Med. 1998. PMID: 9701244 Free article.

6

FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.

Hajitou A, Baramova EN, Bajou K, Noë V, Bruyneel E, Mareel M, Collette J, Foidart JM, Calberg-Bacq CM. Hajitou A, et al. Among authors: bajou k. Oncogene. 1998 Oct 22;17(16):2059-71. doi: 10.1038/sj.onc.1202126. Oncogene. 1998. PMID: 9798677

7

Emerging roles for proteinases in cancer.

Noël A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM. Noël A, et al. Among authors: bajou k. Invasion Metastasis. 1997;17(5):221-39. Invasion Metastasis. 1997. PMID: 9876217 Free article. Review.

8

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.

Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noël A. Bajou K, et al. J Cell Biol. 2001 Feb 19;152(4):777-84. doi: 10.1083/jcb.152.4.777. J Cell Biol. 2001. PMID: 11266468 Free PMC article.

9

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

Lambert V, Munaut C, Noël A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM, Rakic JM. Lambert V, et al. Among authors: bajou k. FASEB J. 2001 Apr;15(6):1021-7. doi: 10.1096/fj.00-0393com. FASEB J. 2001. PMID: 11292663 Free article.

10

New functions of stromal proteases and their inhibitors in tumor progression.

Noel A, Albert V, Bajou K, Bisson C, Devy L, Frankenne F, Maquoi E, Masson V, Sounni NE, Foidart JM. Noel A, et al. Among authors: bajou k. Surg Oncol Clin N Am. 2001 Apr;10(2):417-32, x-xi. Surg Oncol Clin N Am. 2001. PMID: 11382595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page